Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
55.89 USD | -0.29% | +0.41% | +24.66% |
Apr. 12 | Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 | MT |
Apr. 08 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
Official Publications
- Stock Market
- Equities
- CTLT Stock
- News Catalent, Inc.
- Official Publications